PENUMBRA INC (PEN) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:PEN - US70975L1070 - Common Stock
300.66 USD
+5.94 (+2.02%)
300.66 USD
0 (0%)
PEN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. While PEN has a great health rating, its profitability is only average at the moment. PEN is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings could make PEN a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
PEN had positive earnings in the past year.
In the past year PEN had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: PEN reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: PEN reported negative operating cash flow in multiple years.
1.2 Ratios
PEN has a better Return On Assets (9.40%) than 91.98% of its industry peers.
With an excellent Return On Equity value of 12.07%, PEN belongs to the best of the industry, outperforming 88.77% of the companies in the same industry.
With an excellent Return On Invested Capital value of 7.37%, PEN belongs to the best of the industry, outperforming 82.35% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for PEN is significantly below the industry average of 8.81%.
The 3 year average ROIC (2.98%) for PEN is below the current ROIC(7.37%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.4% | ||
| ROE | 12.07% | ||
| ROIC | 7.37% |
ROA(3y)2.2%
ROA(5y)1.03%
ROE(3y)2.91%
ROE(5y)1.37%
ROIC(3y)2.98%
ROIC(5y)N/A
1.3 Margins
PEN has a Profit Margin of 12.30%. This is amongst the best in the industry. PEN outperforms 88.77% of its industry peers.
PEN's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 12.95%, PEN belongs to the top of the industry, outperforming 80.21% of the companies in the same industry.
PEN's Operating Margin has declined in the last couple of years.
PEN has a Gross Margin of 66.80%. This is in the better half of the industry: PEN outperforms 70.05% of its industry peers.
In the last couple of years the Gross Margin of PEN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.95% | ||
| PM (TTM) | 12.3% | ||
| GM | 66.8% |
OM growth 3Y43.4%
OM growth 5Y-3.62%
PM growth 3Y18.27%
PM growth 5Y-33.26%
GM growth 3Y-0.21%
GM growth 5Y-1.44%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PEN is destroying value.
The number of shares outstanding for PEN has been reduced compared to 1 year ago.
PEN has more shares outstanding than it did 5 years ago.
The debt/assets ratio for PEN has been reduced compared to a year ago.
2.2 Solvency
PEN has an Altman-Z score of 20.23. This indicates that PEN is financially healthy and has little risk of bankruptcy at the moment.
PEN's Altman-Z score of 20.23 is amongst the best of the industry. PEN outperforms 95.19% of its industry peers.
The Debt to FCF ratio of PEN is 0.15, which is an excellent value as it means it would take PEN, only 0.15 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.15, PEN belongs to the top of the industry, outperforming 93.58% of the companies in the same industry.
A Debt/Equity ratio of 0.02 indicates that PEN is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.02, PEN is doing good in the industry, outperforming 71.66% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.15 | ||
| Altman-Z | 20.23 |
ROIC/WACC0.84
WACC8.77%
2.3 Liquidity
PEN has a Current Ratio of 6.73. This indicates that PEN is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 6.73, PEN belongs to the best of the industry, outperforming 85.03% of the companies in the same industry.
PEN has a Quick Ratio of 4.18. This indicates that PEN is financially healthy and has no problem in meeting its short term obligations.
PEN has a better Quick ratio (4.18) than 76.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.73 | ||
| Quick Ratio | 4.18 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 36.47% over the past year.
The Earnings Per Share has been growing by 24.23% on average over the past years. This is a very strong growth
Looking at the last year, PEN shows a quite strong growth in Revenue. The Revenue has grown by 14.61% in the last year.
PEN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.89% yearly.
EPS 1Y (TTM)36.47%
EPS 3Y60.05%
EPS 5Y24.23%
EPS Q2Q%14.12%
Revenue 1Y (TTM)14.61%
Revenue growth 3Y16.91%
Revenue growth 5Y16.89%
Sales Q2Q%17.82%
3.2 Future
The Earnings Per Share is expected to grow by 24.42% on average over the next years. This is a very strong growth
PEN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.24% yearly.
EPS Next Y32.46%
EPS Next 2Y33.3%
EPS Next 3Y31.11%
EPS Next 5Y24.42%
Revenue Next Year15.96%
Revenue Next 2Y15.04%
Revenue Next 3Y14.5%
Revenue Next 5Y13.24%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 82.83, the valuation of PEN can be described as expensive.
Based on the Price/Earnings ratio, PEN is valued a bit cheaper than 65.78% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.49. PEN is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 58.96 indicates a quite expensive valuation of PEN.
PEN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. PEN is cheaper than 67.91% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.69. PEN is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 82.83 | ||
| Fwd PE | 58.96 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PEN is valued a bit cheaper than the industry average as 65.78% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, PEN is valued a bit cheaper than 71.12% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 77.14 | ||
| EV/EBITDA | 58.77 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PEN does not grow enough to justify the current Price/Earnings ratio.
PEN has a very decent profitability rating, which may justify a higher PE ratio.
PEN's earnings are expected to grow with 31.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.55
PEG (5Y)3.42
EPS Next 2Y33.3%
EPS Next 3Y31.11%
5. Dividend
5.1 Amount
PEN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
300.66
+5.94 (+2.02%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners97.87%
Inst Owner Change6.18%
Ins Owners3.7%
Ins Owner Change6.84%
Market Cap11.77B
Revenue(TTM)1.33B
Net Income(TTM)164.03M
Analysts83.33
Price Target319.31 (6.2%)
Short Float %4.5%
Short Ratio3.93
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.92%
Min EPS beat(2)3.63%
Max EPS beat(2)4.22%
EPS beat(4)4
Avg EPS beat(4)9.67%
Min EPS beat(4)3.63%
Max EPS beat(4)23.86%
EPS beat(8)8
Avg EPS beat(8)11.2%
EPS beat(12)12
Avg EPS beat(12)25.5%
EPS beat(16)14
Avg EPS beat(16)17.71%
Revenue beat(2)2
Avg Revenue beat(2)2.8%
Min Revenue beat(2)2.56%
Max Revenue beat(2)3.05%
Revenue beat(4)4
Avg Revenue beat(4)1.89%
Min Revenue beat(4)0.28%
Max Revenue beat(4)3.05%
Revenue beat(8)6
Avg Revenue beat(8)0.73%
Revenue beat(12)10
Avg Revenue beat(12)1.17%
Revenue beat(16)12
Avg Revenue beat(16)1.31%
PT rev (1m)-0.35%
PT rev (3m)-0.1%
EPS NQ rev (1m)-1.87%
EPS NQ rev (3m)-1.9%
EPS NY rev (1m)0.7%
EPS NY rev (3m)0.96%
Revenue NQ rev (1m)0.04%
Revenue NQ rev (3m)0.1%
Revenue NY rev (1m)1.09%
Revenue NY rev (3m)1.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 82.83 | ||
| Fwd PE | 58.96 | ||
| P/S | 8.83 | ||
| P/FCF | 77.14 | ||
| P/OCF | 57.92 | ||
| P/B | 8.67 | ||
| P/tB | 9.93 | ||
| EV/EBITDA | 58.77 |
EPS(TTM)3.63
EY1.21%
EPS(NY)5.1
Fwd EY1.7%
FCF(TTM)3.9
FCFY1.3%
OCF(TTM)5.19
OCFY1.73%
SpS34.06
BVpS34.7
TBVpS30.28
PEG (NY)2.55
PEG (5Y)3.42
Graham Number53.23
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.4% | ||
| ROE | 12.07% | ||
| ROCE | 10.97% | ||
| ROIC | 7.37% | ||
| ROICexc | 10.5% | ||
| ROICexgc | 12.46% | ||
| OM | 12.95% | ||
| PM (TTM) | 12.3% | ||
| GM | 66.8% | ||
| FCFM | 11.44% |
ROA(3y)2.2%
ROA(5y)1.03%
ROE(3y)2.91%
ROE(5y)1.37%
ROIC(3y)2.98%
ROIC(5y)N/A
ROICexc(3y)3.84%
ROICexc(5y)N/A
ROICexgc(3y)4.75%
ROICexgc(5y)N/A
ROCE(3y)4.43%
ROCE(5y)N/A
ROICexgc growth 3Y49.31%
ROICexgc growth 5Y-5.8%
ROICexc growth 3Y58%
ROICexc growth 5Y-7.52%
OM growth 3Y43.4%
OM growth 5Y-3.62%
PM growth 3Y18.27%
PM growth 5Y-33.26%
GM growth 3Y-0.21%
GM growth 5Y-1.44%
F-Score7
Asset Turnover0.76
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.15 | ||
| Debt/EBITDA | 0.11 | ||
| Cap/Depr | 291.22% | ||
| Cap/Sales | 3.8% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 106.89% | ||
| Profit Quality | 93.05% | ||
| Current Ratio | 6.73 | ||
| Quick Ratio | 4.18 | ||
| Altman-Z | 20.23 |
F-Score7
WACC8.77%
ROIC/WACC0.84
Cap/Depr(3y)74.85%
Cap/Depr(5y)109.14%
Cap/Sales(3y)1.83%
Cap/Sales(5y)2.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.47%
EPS 3Y60.05%
EPS 5Y24.23%
EPS Q2Q%14.12%
EPS Next Y32.46%
EPS Next 2Y33.3%
EPS Next 3Y31.11%
EPS Next 5Y24.42%
Revenue 1Y (TTM)14.61%
Revenue growth 3Y16.91%
Revenue growth 5Y16.89%
Sales Q2Q%17.82%
Revenue Next Year15.96%
Revenue Next 2Y15.04%
Revenue Next 3Y14.5%
Revenue Next 5Y13.24%
EBIT growth 1Y54.5%
EBIT growth 3Y67.65%
EBIT growth 5Y12.66%
EBIT Next Year81.21%
EBIT Next 3Y42.41%
EBIT Next 5Y26.5%
FCF growth 1Y222.8%
FCF growth 3YN/A
FCF growth 5Y100.55%
OCF growth 1Y225.73%
OCF growth 3Y160.78%
OCF growth 5Y44.6%
PENUMBRA INC / PEN FAQ
What is the ChartMill fundamental rating of PENUMBRA INC (PEN) stock?
ChartMill assigns a fundamental rating of 6 / 10 to PEN.
Can you provide the valuation status for PENUMBRA INC?
ChartMill assigns a valuation rating of 4 / 10 to PENUMBRA INC (PEN). This can be considered as Fairly Valued.
What is the profitability of PEN stock?
PENUMBRA INC (PEN) has a profitability rating of 6 / 10.
What are the PE and PB ratios of PENUMBRA INC (PEN) stock?
The Price/Earnings (PE) ratio for PENUMBRA INC (PEN) is 82.83 and the Price/Book (PB) ratio is 8.67.
Can you provide the financial health for PEN stock?
The financial health rating of PENUMBRA INC (PEN) is 8 / 10.